What is HC Wainwright’s Forecast for ZVRA Q1 Earnings?
HC Wainwright issued their Q1 2025 EPS estimates for shares of Zevra Therapeutics in a note issued to investors on Thursday, ...
What is HC Wainwright’s Forecast for ONCY FY2027 Earnings?
Investment analysts at HC Wainwright boosted their FY2027 EPS estimates for shares of Oncolytics Biotech in a research report ...
Stocktwits on MSN3d
Core Scientific Stock Gains As HC Wainwright Reiterates Rating On CoreWeave's $12B OpenAI Deal: Retail Stays Extremely Bullish
Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...
ProQR Therapeutics price target raised to $12 from $10 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on ProQR Therapeutics (PRQR) to $12 from $10 and keeps a Buy rating on the shares. The firm says ...
Fintel on MSN2d
HC Wainwright & Co. Initiates Coverage of Perspective Therapeutics (CATX) with Buy Recommendation
Fintel reports that on March 13, 2025, HC Wainwright & Co. initiated coverage of Perspective Therapeutics (NYSEAM:CATX) with ...
IN8bio price target lowered to $6 from $8 at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth lowered the firm’s price target on IN8bio (INAB) to $6 from $8 and keeps a Buy rating on the ...
CoinDesk4d
U.S. Strategic Bitcoin Reserve a 'Monumental Endorsement' of the Crypto: H.C. Wainwright
The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
H.C. Wainwright & Co. initiates a Buy rating on Perspective Therapeutics, citing promising cancer radiotherapy assets.
Nanoscope Therapeutics to Present at the H.C. Wainwright 3rd Annual BioConnect Showcase
Nanoscope Therapeutics Inc., a biotech company committed to restoring vision in individuals who are blind or losing vision ...
Nasdaq11d
HC Wainwright & Co. Initiates Coverage of Inuvo (INUV) with Buy Recommendation
Fintel reports that on March 11, 2025, HC Wainwright & Co. initiated coverage of Inuvo (NYSEAM:INUV) with a Buy recommendation. As of March 4, 2025, the average one-year price target for Inuvo is ...
Cantargia to Participate at H.C. Wainwright’s Annual Autoimmune & Inflammatory Virtual Conference
Cantargia AB (publ) ("Cantargia") (Nasdaq Stockholm: CANTA) today announced that Damian Marron, Interim CEO, will participate ...
Nasdaq4d
HC Wainwright & Co. Initiates Coverage of Westwater Resources (WWR) with Buy Recommendation
Fintel reports that on March 11, 2025, HC Wainwright & Co. initiated coverage of Westwater Resources (NYSEAM:WWR) with a Buy recommendation. What is the Fund Sentiment? There are 59 funds or ...